logo
Select company
Select metric
-225.79%EBIT Margin
VS
Market
10
Sector
32
Industry
57
History
100
$ 14.01Close
$ 2.29 - $ 18.94 52-Week Range
Ticker Information

Ticker

PHAT

Company Name

PHATHOM PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHATHOM PHARMACEUTICALS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PHAT - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -257.49M-225.79%$ 114.04M
3/31/2025$ -272.88M-333.35%$ 81.86M
12/31/2024$ -262.32M-474.76%$ 55.25M
9/30/2024$ -273M-1039.21%$ 26.27M
6/30/2024$ -239.04M-2410.19%$ 9.92M
3/31/2024$ -196.71M-7583.31%$ 2.59M
12/31/2023$ -159.62M-23405.28%$ 682K
9/30/2023$ -138.53M0%$ 0
6/30/2023$ -147.21M0%$ 0
3/31/2023$ -161.11M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHATHOM PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, PHATHOM PHARMACEUTICALS INC's average EBIT % has been -5067.41%.
  • The median EBIT % for PHATHOM PHARMACEUTICALS INC during this period was -1039.21%
  • PHATHOM PHARMACEUTICALS INC reached its highest EBIT % over the past 5 years at -225.79%.
  • The lowest EBIT % recorded by PHATHOM PHARMACEUTICALS INC in the same timeframe -23405.28%

PHATHOM PHARMACEUTICALS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
GYRE : GYRE THERAPEUTICS INC 6.85%ANAB : ANAPTYSBIO INC -107.59%NAGE : NIAGEN BIOSCIENCE INC 15.76%CRMD : CORMEDIX INC 42.57%TBPH : THERAVANCE BIOPHARMA INC 55.25%ZYME : ZYMEWORKS INC -54.88%URGN : UROGEN PHARMA LTD -144.32%ZVRA : ZEVRA THERAPEUTICS INC 48.18%XNCR : XENCOR INC -91.72%KURA : KURA ONCOLOGY INC -232.16%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for PHATHOM PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -169.03M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

PHAT - EBIT Margin, Last 5 years

-23405.28%

Minimum

Dec 31, 2023

-225.79%

Maximum

Jun 30, 2025

-5067.41%

Average

-1039.21%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.95%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.95%